[1] |
TANG Duocai, ZHOU Shukui, ZHANG Guiyin, LIU Lei, LIAO Hong.
Analysis of risk factors of recurrence in non-muscle invasive bladder cancer patients after initial transurethral resection of bladder tumor
[J]. China Oncology, 2023, 33(5): 478-483.
|
[2] |
CAO Mengxuan, HU Can, ZHANG Yanqiang, HUANG Ling, DU Yian, YU Pengcheng, ZHANG Ruolan, XU Zhiyuan, CHENG Xiangdong.
Analysis of risk factors of early recurrence and metastasis after radical resection of gastric cancer
[J]. China Oncology, 2022, 32(7): 588-595.
|
[3] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|
[4] |
CAO Wei, HE Yingjian, Li Jinfeng, XIE Yuntao, WANG Tianfeng, FAN Tie, WANG Xinguang, WANG Xing, FAN Zhaoqing.
Risk factors of pathological underestimation in breast ductal carcinoma in situ diagnosed by ultrasound-guided core needle biopsy
[J]. China Oncology, 2020, 30(3): 217-223.
|
[5] |
DING Pingan, YANG Peigang, TIAN Yuan, GUO Ziyang, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun.
Effect of extranodal invasion on survival and prognosis of gastric cancer patients: a report of 2 386 cases
[J]. China Oncology, 2020, 30(12): 1017-1025.
|
[6] |
XIAO Jialong, ZHENG Ying.
The global prevalence and prevention progress of lung cancer
[J]. China Oncology, 2020, 30(10): 721-725.
|
[7] |
MA Xiaokai,HUANG Jiankang,ZHU Bo,PENG Defeng,ZHOU Rui,WANG Shengying .
Clinical characteristics of papillary thyroid microcarcinoma and risk factors for cervical lymph node metastasis: a clinical analysis of 228 cases
[J]. China Oncology, 2019, 29(8): 590-594.
|
[8] |
MIAO Changfeng,MA Yuntao,WANG Xiaopeng,HU Ming,YANG Xiaojun .
Construction of the risk factor model of gastric cancer and its value in screening opportunity and options
[J]. China Oncology, 2019, 29(7): 501-507.
|
[9] |
LIU Shan, FANG Juan, WANG Lili, ZHANG Yinghong, DU Wenjie, ZHU Taohua.
Association between peripheral nerve invasion and recurrence risk factors in cervical cancer
[J]. China Oncology, 2019, 29(6): 439-444.
|
[10] |
LIU Xiaoxue, YU Chuanhua, ZHOU Wei, et al.
Trends in colorectal cancer mortality for the last 30 years in China
[J]. China Oncology, 2018, 28(3): 177-183.
|
[11] |
LIN Xuedan, YANG Tianxing,TAO Zhihua.
Predictive value of CEA and CA19-9 for recurrence in stage Ⅱ-Ⅲ colon cancer
[J]. China Oncology, 2018, 28(11): 827-832.
|
[12] |
ZHANG Shunkang, ZHENG Leizhen, CHEN Gang, et al.
Anylasis of risk factors for arm lymphedema in breast cancer patients treated with neoadjuvant chemotherapy
[J]. China Oncology, 2017, 27(10): 815-821.
|
[13] |
SHEN Lihua, ZHANG Zhongwei, ZHU Biao.
Clinical analysis of tumor related venous thromboembolism: 196 cases
[J]. China Oncology, 2016, 26(4): 338-345.
|
[14] |
ZHANG Lei, YANG Jinbao, FAN Yufang, et al.
Risk factors of lymph node metastasis in cN0 papillary thyroid carcinoma
[J]. China Oncology, 2016, 26(1): 73-79.
|
[15] |
DONG Fen, ZHANG Biao, SHAN Guangliang.
Distribution and risk factors of thyroid cancer in China
[J]. China Oncology, 2016, 26(1): 47-52.
|